scout
|Videos|January 30, 2023

Combination Ruxolitinib and Selinexor for the Treatment of Naïve Myelofibrosis

Srdan Verstovsek, MD, reviews data presented at ASH 2022 on combination ruxolitinib and selinexor for the frontline treatment of myelofibrosis.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME